• Nachrichtendetail
• 

26.04.2024 14:21:38 - dpa-AFX: *CHMP BACKS J&J'S RYBREVANT COMBO FOR FIRST-LINE NSCLC WITH EGFR EXON 20 MUTATION

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	JOHNSON + JOHNSON DL 1	853260	Xetra	139,160	13.05.24 15:45:12	+0,280	+0,20%	139,240	139,440	139,980	138,880